Conference
PMD19 COST-EFFECTIVENESS OF EPIDERMAL GROWTH FACTOR RECEPTOR GENE MUTATION TESTING IN THE SELECTION OF FIRST-LINE THERAPY FOR PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER IN ONTARIO
Authors
Chen W; Ellis P; Levin L; Krahn M
Volume
14
Publisher
Elsevier
Publication Date
5 2011
DOI
10.1016/j.jval.2011.02.459
Conference proceedings
Value in Health
Issue
3
ISSN
1098-3015